Chronic Hepatitis D Infection Clinical Trial
Official title:
A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection
The main goal of this study is to collect post marketing data from patients with chronic hepatitis D virus (HDV) infection who are treated with bulevirtide to describe the long-term effects of bulevirtide treatment and evaluate the safety of participants treated with bulevirtide.
The study design time perspective is retrospective and prospective for participants who previously participated in MYR-Reg-02 and are currently receiving BLV and prospective for participants who are scheduled to receive BLV. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05827146 -
Study of Hepalatide in Chronic Hepatitis D(CHD) Patients
|
Phase 2 | |
| Completed |
NCT02430181 -
Lonafarnib With and Without Ritonavir in HDV (LOWR-1)
|
Phase 2 | |
| Recruiting |
NCT05760300 -
A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function
|
Phase 1 | |
| Recruiting |
NCT05765344 -
Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function
|
Phase 1 | |
| Recruiting |
NCT06248580 -
Find HDV and Determine Its Status in Turkey
|
||
| Completed |
NCT02637999 -
Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04638439 -
The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection
|
Phase 1 | |
| Completed |
NCT02430194 -
Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2)
|
Phase 2 |